Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.56), $0.15 better than the analyst estimate of ($1.71). Revenue for the quarter came in at $10.5 million versus the consensus estimate of $8.07 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.